This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Europe: Oligonucleotide and Peptide Therapeutics
11-13 November 2025
Congress Center BaselBasel, Switzerland

Jonathan Dorigatti, PhD
Scientist II, ECO Process Development at Codexis
Speaker

Profile

Dr. Jonathan Dorigatti joined Codexis in 2021 as a Product Development Scientist within the Life Sciences division where he contributed to the development of the Codex® HiCap RNA Polymerase. In 2024, he transitioned to the ECO Process Development team where he now leads the development of Codexis' NQP (nucleoside quadriphosphate) process, a critical component of the company's ECO Synthesis™ platform. This enzymatic approach aims to provide a more efficient and cost-effective method for producing nucleotide quadriphosphates essential for RNA synthesis, offering a sustainable alternative to traditional chemical processes.
Prior to joining Codexis, Dr. Dorigatti worked at BioFire Diagnostics, focusing on the production of oligonucleotides for point-of-care diagnostic kits. He earned his B.S. in Cell and Molecular Biology from the University of Utah and his Ph.D. in Integrated Biomedical Sciences with a specialization in the biology of aging from the University of Texas Health Science Center at San Antonio.

Agenda Sessions

  • Building a Robust & Sustainable Process for Raw Material Supply: Enzymatic Synthesis of Nucleoside Quad Phosphates (NQPs)

    12:40